Original language | English (US) |
---|---|
Pages (from-to) | E112-E114 |
Journal | Journal of Acquired Immune Deficiency Syndromes |
Volume | 79 |
Issue number | 5 |
DOIs | |
State | Published - Dec 15 2018 |
ASJC Scopus subject areas
- Infectious Diseases
- Pharmacology (medical)
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy. / Gianella, Sara; Marconi, Vincent C.; Berzins, Baiba; Benson, Constance A.; Sax, Paul; Fichtenbaum, Carl J.; Wilkin, Timothy; Vargas, Millie; Deng, Qianqian; Oliveira, Michelli F.; Moser, Carlee; Taiwo, Babafemi O.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 79, No. 5, 15.12.2018, p. E112-E114.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy
AU - Gianella, Sara
AU - Marconi, Vincent C.
AU - Berzins, Baiba
AU - Benson, Constance A.
AU - Sax, Paul
AU - Fichtenbaum, Carl J.
AU - Wilkin, Timothy
AU - Vargas, Millie
AU - Deng, Qianqian
AU - Oliveira, Michelli F.
AU - Moser, Carlee
AU - Taiwo, Babafemi O.
N1 - Funding Information: B.O.T. has served as a paid consultant to ViiV, Gilead, and Janssen and on the Clinical Care Options speakers bureau and has received grant funding to his institution from ViiV/GlaxoS-mithKline (GSK). V.C.M., C.J.F., C.A.B., T.W., have received grant funding for this study to their institutions through Northwestern University from ViiV/GSK. The remaining authors have no funding or conflicts of interest to disclose. Funding Information: Supported by an Investigator Sponsored Study grant ?Virologic Activity of DTG +3TC in the Genital Compartment: Substudy of ASPIRE and A5353? from ViiV Healthcare to Northwestern University. ViiV Healthcare/GlaxoSmithKline provided funding and study drugs. Additional support was provided from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636, and UM1 AI106701, the San Diego Center for AIDS Research Translational Virology Core (P30AI036214) as well as the Third Coast Center for AIDS Research (P30AI117943), and Emory Center for AIDS Research (P30AI050409). Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq)-Brazil. Funding Information: Supported by an Investigator Sponsored Study grant “Virologic Activity of DTG +3TC in the Genital Compartment: Substudy of ASPIRE and A5353” from ViiV Healthcare to Northwestern University. ViiV Healthcare/GlaxoSmithKline provided fund-ing and study drugs. Additional support was provided from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number UM1 AI068634, UM1 AI068636, and UM1 AI106701, the San Diego Center for AIDS Research Translational Virology Core (P30AI036214) as well as the Third Coast Center for AIDS Research (P30AI117943), and Emory Center for AIDS Research (P30AI050409). Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-Brazil.
PY - 2018/12/15
Y1 - 2018/12/15
UR - http://www.scopus.com/inward/record.url?scp=85056322586&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056322586&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000001863
DO - 10.1097/QAI.0000000000001863
M3 - Letter
C2 - 30383591
AN - SCOPUS:85056322586
VL - 79
SP - E112-E114
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
SN - 1525-4135
IS - 5
ER -